These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23249695)

  • 21. Induction of hyperandrogenism in lean reproductive-age women stimulates proatherogenic inflammation.
    González F; Sreekumaran Nair K; Basal E; Bearson DM; Schimke JM; Blair HE
    Horm Metab Res; 2015 Jun; 47(6):439-44. PubMed ID: 25230323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated circulating levels of macrophage migration inhibitory factor in polycystic ovary syndrome.
    González F; Rote NS; Minium J; Weaver AL; Kirwan JP
    Cytokine; 2010 Sep; 51(3):240-4. PubMed ID: 20598902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic β-cell dysfunction in polycystic ovary syndrome: role of hyperglycemia-induced nuclear factor-κB activation and systemic inflammation.
    Malin SK; Kirwan JP; Sia CL; González F
    Am J Physiol Endocrinol Metab; 2015 May; 308(9):E770-7. PubMed ID: 25714674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome.
    González F; Rote NS; Minium J; Kirwan JP
    J Clin Endocrinol Metab; 2006 Jan; 91(1):336-40. PubMed ID: 16249279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid-induced mononuclear cell cytokine secretion in the development of metabolic aberration and androgen excess in polycystic ovary syndrome.
    González F; Considine RV; Abdelhadi OA; Acton AJ
    Hum Reprod; 2020 May; 35(5):1168-1177. PubMed ID: 32325487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of PON1 activity and circulating TF levels in relation to BMI, testosterone, HOMA-IR, HDL-C, LDL-C, CHO, SOD activity and TAC in women with PCOS: An observational study.
    Jeelani H; Ganie MA; Masood A; Amin S; Kawa IA; Fatima Q; Manzoor S; Parvez T; Naikoo NA; Rashid F
    Diabetes Metab Syndr; 2019; 13(5):2907-2915. PubMed ID: 31425955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
    Durmus U; Duran C; Ecirli S
    J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction.
    González F
    Steroids; 2012 Mar; 77(4):300-5. PubMed ID: 22178787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The polycystic ovary syndrome per se is not associated with increased chronic inflammation.
    Möhlig M; Spranger J; Osterhoff M; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Eur J Endocrinol; 2004 Apr; 150(4):525-32. PubMed ID: 15080783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism.
    Castelo-Branco C; Steinvarcel F; Osorio A; Ros C; Balasch J
    Gynecol Endocrinol; 2010 Oct; 26(10):736-42. PubMed ID: 20569105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome.
    Faloia E; Canibus P; Gatti C; Frezza F; Santangelo M; Garrapa GG; Boscaro M
    J Endocrinol Invest; 2004 May; 27(5):424-9. PubMed ID: 15279073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome.
    Tosi F; Dorizzi R; Castello R; Maffeis C; Spiazzi G; Zoppini G; Muggeo M; Moghetti P
    Eur J Endocrinol; 2009 Nov; 161(5):737-45. PubMed ID: 19713424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory Markers in Women with Polycystic Ovary Syndrome.
    Rudnicka E; Kunicki M; Suchta K; Machura P; Grymowicz M; Smolarczyk R
    Biomed Res Int; 2020; 2020():4092470. PubMed ID: 32219132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing C reactive protein/albumin ratio as a new biomarker for polycystic ovary syndrome: a case-control study of women from Bahraini medical clinics.
    Kalyan S; Goshtesabi A; Sarray S; Joannou A; Almawi WY
    BMJ Open; 2018 Oct; 8(10):e021860. PubMed ID: 30368447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of interlukin-6 on central obesity measures in women with polycystic ovarian syndrome.
    Alissa EM; Algarni SA; Khaffji AJ; Al Mansouri NM
    J Obstet Gynaecol; 2020 Nov; 40(8):1133-1137. PubMed ID: 32157932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
    Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
    Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.
    Zwirska-Korczala K; Sodowski K; Konturek SJ; Kuka D; Kukla M; Brzozowski T; Cnota W; Woźniak-Grygiel E; Jaworek J; Bułdak R; Rybus-Kalinowska B; Fryczowski M
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():161-78. PubMed ID: 18812636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating high-sensitivity C-reactive protein and soluble CD40 ligand are inter-related in a cohort of women with polycystic ovary syndrome.
    El-Mesallamy HO; Abd El-Razek RS; El-Refaie TA
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):178-82. PubMed ID: 23434327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome.
    Barrea L; Marzullo P; Muscogiuri G; Di Somma C; Scacchi M; Orio F; Aimaretti G; Colao A; Savastano S
    Nutr Res Rev; 2018 Dec; 31(2):291-301. PubMed ID: 30033891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.